GNI GNI GROUP LTD.

Contact Us
About Us
  • About Us TOP
  • Message
  • Business Model
  • Main Products
  • Management Policy
  • Company Overview
  • Board of Directors
  • Main Group Structure
  • Office
  • Corporate governance
R&D
  • R&D TOP
  • Pipeline
  • Discovery Research
  • Research publications
Investor Relations
  • Investor Relations TOP
  • IR News
  • Information
  • IR Materials
  • IR Calendar
  • IR Email Subscription
  • Electronic Public Notices
Sustainability/ESG
  • Sustainability/ESG TOP
  • Sustainability Initiatives
  • ESG Data
Contact Us
Site Map
Privacy Policy
Terms of Use
ソーシャルメディアポリシー

2015's Information

トップページInformation2015年
2015/12/08
57th Annual General Meeting of the American Society of Hematology Presentation of clinical trial results from China on tamibarotene as a treatment for acute promyelocytic leukemia
2015/07/06
Macquarie Securities report on GNI was posted on Bloomberg
2015/04/27
Initiation of Postmarketing Surveillance Studies of Etuary
2015/03/06
Notice of email server maintenance
2015/02/27
Announcement of the 14th Annual General Shareholder Meeting
2015/01/30
Notice of Completion of Investment inIriSys, LLC
2015/01/20
Notice of Investment in IriSys, LLC and Establishment of New U.S. Subsidiary
画像

GNI

About Us
Message
Business Model
Main Products
Management Policy
Company Overview
Board of Directors
Main Group Structure
Office
Corporate Governance Policy
Investor Relations
IR News
IR Materials
IR Calendar
Electronic Public Notices
IR Email Subscription
R&D
Pipeline
Discovery Research
Research publications
Sustainability/ESG
Sustainability Initiatives
ESG Data
Contact Us
Career
Site Map
Privacy Policy
Terms of Use
Social Media Policy
Site Map
Privacy Policy
Terms of Use
Social Media Policy

© GNI Group Ltd. All Rights Reserved.